CD300LG and diffuse large B-cell lymphoma: It was revealed that CCDC78, CD300LG, CTAG2, DYNLL2, MAPKAPK2, MREG, NME8, PGK2, RALBP1, SIGLEC1, SLC1A1, SLC39A12, TMEM63A, and WRAP73 were significantly associated with the OS rate of DLBCL patients (Figure 2C and Supplementary Figures S1A–S1N).